OVERVIEW
This live panel discussion at ONS Congress 2024 will be focused on real world best practices around the use of bispecific antibodies for the treatment of lymphomas. The program will include nursing leaders in the field of lymphoma discussing the current treatment landscape, shared decision making with the patient and caregiver, key differences between therapeutic options, and successful management of adverse events.
GOAL STATEMENT
The goal of this activity is for learners to be better able to differentiate among bispecific antibodies used in the treatment of lymphomas (eg, diffuse large B-cell lymphoma [DLBCL], follicular lymphoma [FL]) and take a patient-centric approach to their management.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the[LIST][ITEM]Role of bispecific antibodies for lymphomas[/LIST]Have greater competence related to[LIST][ITEM]Managing adverse events (AEs) in patients with lymphomas undergoing treatment with bispecific antibodies[/LIST]Demonstrate greater confidence in their ability to[LIST][ITEM]Discuss management considerations for patients receiving bispecific antibodies for the treatment of lymphomas[/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Nurses[/bold] Awarded 1.50 contact hour(s) of nursing continuing professional development for RNs and APNs.
Marriott Marquis Washington, DC
Marquis Ballroom, Salon 5
901 Massachusetts Ave NW
Washington, District of Columbia, 20001
Meeting space has been assigned to provide a symposium supported by Medscape Oncology during the Oncology Nursing Society’s (ONS) 49th Annual Congress, April 24 – April 28, 2024 in Washington, D.C. The Oncology Nursing Society's assignment of meeting space does not imply product endorsement.
Supported by an independent educational grant from [bold]Regeneron Pharmaceuticals, Inc[/bold].